Vlad Coric

Chairman and CEO of Biohaven, a biotech company focused on neurology and immunology; discusses company pipeline including degraders, TYK2/JAK1, myostatin approaches for obesity, and a Kv7 epilepsy program.

Best podcasts with Vlad Coric

Ranked by the Snipd community

Jan 12, 2026 • 11min

SF Healthcare Week: Biohaven's Chairman & CEO Vlad Coric shares updates on the company's pipeline in immunology, obesity, and epilepsy

Vlad Coric, Chairman and CEO of Biohaven and an expert in neurology and immunology, dives into the company’s innovative pipeline. He highlights the degrader programs targeting immunology and discusses a brain-penetrant TYK2/JAK1 inhibitor for Parkinson's. Coric also shares insights about a myostatin approach to tackle obesity and preserve muscle, and the promising Kv7 epilepsy program, emphasizing upcoming trial data. His commitment to ataxia patients and navigating FDA challenges adds depth to this engaging conversation.

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app